Learning from the Patient in ADHD: A Standardized Patient Program

Program Overview

Once thought of as a childhood disorder that primarily affected “disruptive” boys, attention-deficit hyperactivity disorder (ADHD) is now known to persist into adulthood in about two-thirds of cases, with an overall prevalence of 3%–5% of US adults. Although adult ADHD severely impacts patients and families, the condition remains underdiagnosed/misdiagnosed and inadequately treated. Since ADHD is frequently perceived to be a childhood disorder, its diagnosis in adults may not be considered. Validated tools are often not used to assess ADHD, which leads to missed diagnoses and impedes optimal monitoring and revision of treatment. Finally, patient communication is paramount to optimal treatment and clinicians need to become more comfortable with communicating and educating their patients.

In this activity, participants will be able to observe an ideal office visit to evaluate and treat a patient with ADHD, including a demonstration of shared decision making techniques. A variety of learner challenge questions will be included throughout the activity, along with peer benchmarking and faculty feedback.  After the activity, participants will receive a series of three messages to reinforce key teaching points, based on unique educational gaps uncovered in the program.

NACE Accreditation Statement

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NACE Credit Designation Statement

The National Association for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NACE AANP Approval

National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 1.0 contact hours including 0.5 Pharmacology Hours

How to claim credit

1.          Review the curriculum front matter.

2.          Participate in the curriculum.

3.          Complete the post-test and activity evaluation.

4.          You must score 70% or higher on the post-test to receive credit for this activity.

Policy on Faculty and Provider Disclosure

Accredited education provided by the National Association for Continuing Education (NACE) must demonstrate balance, independence, objectivity, and scientific rigor. All individuals in a position to influence content of NACE accredited education are required to disclose all financial relationships with ineligible companies within the previous 24 month period, regardless of relevance to the education. All relevant financial relationships and potential conflicts of interest will be mitigated prior to the activity.

NACE defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Faculty and Planning Committee Disclosures

Gregory Mattingly has disclosed the following financial relationships:

• Consultant: AbbVie, Acadia, Alkermes, Axsome, Eisai, Ironshore, Intracellular, Janssen, Lundbeck, Neos, Neurocrine, Otsuka, Redax, Roche, Rhodes, Sage, Shire, Sunovion, Supernus, Takeda, Teva, Trispharma
• Advisor: Abbvie, Alkermes, Eisai, Janssen, Lundbeck, Neurocrine, Otsuka, Sunovion, Supernus, Takeda, Trispharma
• Speaker: Abbvie, Alkermes, Eisai, Janssen, Lundbeck, Neurocrine, Otsuka, Sunovion, Supernus, Takeda, Trispharma
• Contracted Research: Abbvie, Acadia, Alkermes, Avanir, Axsome, Boehringer, Emalex, Janssen, Medgenics, NLS-1 Pharma AG, Redax, Roche, Sage, Shire, Sunovion, Supernus, Takeda, Teva

All relevant financial relationships and potential conflicts of interest have been mitigated.

Gregg Sherman, MD, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.

Michelle Frisch, MPH, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.

Sheila Lucas, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.

Joshua Kilbridge, Medical Writer, has no relevant conflicts of interest with any ACCME-defined commercial interest.

Angela Golden, DNP, FNP-C, FAANP, Family Nurse Practitioner, has no relevant conflicts of interest with any ACCME-defined commercial interest.

Disclosure of Commercial Support

This activity is supported by an educational grant provided by Takeda, Inc.

Disclosure of Unlabeled/Investigational Uses of Products

The content of the presentations may include discussion of unapproved or investigational uses of product or devices.

Course format/medium: Internet Enduring Activity

Estimated time to complete the activity: 60 minutes

COURSE VIEWING REQUIREMENTS